Trial
NCT04761861
Vildagliptin for Treatment of Antipsychotic-induced Dyslipidemia
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Sadat City University
Collaborators
—
Condition
Schizophrenia
Intervention
Vildagliptin 50 MG
Why stopped
Institutional and funding constrains
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-14